Source:http://linkedlifedata.com/resource/pubmed/id/15140826
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-7-26
|
pubmed:abstractText |
Galectins are a family of beta-galactoside binding molecules involved in cell--extracellular matrix adhesion processes. Specifically, Galectin-3 (Gal-3), one of the members of this family of molecules plays a role in cell adhesion processes as well as in cell survival or apoptosis. Gal-3 was also hypothesized to represent a useful tool in tumor characterization, for example, in thyroid tumors. We report herein the results obtained by evaluating Gal-3 expression of colon cells from human adenomas and adenocarcinomas with two different methodologies: immunohistochemistry and flow cytometry of living dispersed cells. We found that (1) the expression of Gal-3 was significantly increased on the surface of cells from adenomas with respect to normal mucosa from the same patient; (2) Gal-3 ligand, 90k molecule, was increased in the blood plasma from patients with both adenomatous and adenocarcinomatous lesions; and (3) Gal-3 overexpression was not related with the presence of K-ras mutation. Altogether these results clearly indicate that the evaluation of Gal-3 expression (and of its ligand, 90k) can be of interest in the characterization of nonmalignant and malignant colon cancers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0959-6658
|
pubmed:author |
pubmed-author:AssisiDanielaD,
pubmed-author:CasaleVincenzoV,
pubmed-author:CosimelliMaurizioM,
pubmed-author:GiannarelliDianaD,
pubmed-author:GrecoClaudiaC,
pubmed-author:MalorniWalterW,
pubmed-author:MatarresePaolaP,
pubmed-author:MolesAnnaA,
pubmed-author:MottoleseMarcellaM,
pubmed-author:ScordatiPatriziaP,
pubmed-author:StrafaceElisabettaE,
pubmed-author:VonaRosaR
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
783-92
|
pubmed:meshHeading |
pubmed-meshheading:15140826-Adenocarcinoma,
pubmed-meshheading:15140826-Adenoma,
pubmed-meshheading:15140826-Base Sequence,
pubmed-meshheading:15140826-Colonic Neoplasms,
pubmed-meshheading:15140826-DNA Primers,
pubmed-meshheading:15140826-Flow Cytometry,
pubmed-meshheading:15140826-Galectin 3,
pubmed-meshheading:15140826-Genes, ras,
pubmed-meshheading:15140826-Humans,
pubmed-meshheading:15140826-Immunohistochemistry,
pubmed-meshheading:15140826-Ligands,
pubmed-meshheading:15140826-Polymerase Chain Reaction,
pubmed-meshheading:15140826-Polymorphism, Restriction Fragment Length
|
pubmed:year |
2004
|
pubmed:articleTitle |
Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions.
|
pubmed:affiliation |
Clinical Pathology Service, Polo Oncologico Regina Elena, Rome, Italy.
|
pubmed:publicationType |
Journal Article
|